A61K 39/23
Parvoviridae
Official title: Parvoviridae, e.g. feline panleukopenia virus
A61K39/23 (Parvoviridae) appears on 86 US grants and 125 published applications in this corpus.
Search patents in A61K- Granted patents
- 86
- Published applications
- 125
- Assignees
- 66
- Inventors
- 235
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 0 |
| 2004 | 1 | 3 |
| 2005 | 1 | 4 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 1 | 3 |
| 2009 | 1 | 2 |
| 2010 | 2 | 1 |
| 2011 | 0 | 2 |
| 2012 | 2 | 3 |
| 2013 | 2 | 5 |
| 2014 | 0 | 6 |
| 2015 | 2 | 10 |
| 2016 | 5 | 8 |
| 2017 | 9 | 10 |
| 2018 | 6 | 5 |
| 2019 | 8 | 7 |
| 2020 | 6 | 12 |
| 2021 | 4 | 3 |
| 2022 | 3 | 5 |
| 2023 | 9 | 8 |
| 2024 | 9 | 9 |
| 2025 | 3 | 5 |
| 2026 | 4 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Canine parvovirus23 Jun 2026US 12,661,395 B2Intervet Inc.
- Gene therapies for lysosomal disorders10 Mar 2026US 12,570,963 B2Prevail Therapeutics, Inc.
- Endothelium-specific nucleic acid regulatory elements and methods and use thereof24 Feb 2026US 12,558,416 B2Vrije Universiteit Brussel
- Methods and kits for quantifying the removal of mock virus particles from a purified solution17 Feb 2026US 12,553,894 B2Cygnus Technologies, L.L.C.
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- Method for inducing an immune response8 Oct 2026US 2026/0306617 A1Acclarent, Inc.
- A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus8 Oct 2026US 2026/0306618 A1Intervet Inc.
- Nannochloropsis-producing viruses and methods and compositions for making the same1 Oct 2026US 2026/0297502 A1Insmed Incorporated
- Canine parvovirus10 Sep 2026US 2026/0263590 A1Intervet Inc.
- Triple mrna vaccine for preventing feline rhinotracheitis, feline caliciviral disease, and feline panleukopenia, and preparation method thereof6 Aug 2026US 2026/0224690 A1Zhejiang University
Most cited
By later US patents
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- AAV vectors targeted to oligodendrocytes37US 9,636,370 B2The University of North Carolina at Chapel Hill · 2017
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000
- Polynucleotide formula against porcine reproductive and respiratory pathologies31US 6,207,165 B1Merial Limited · 2001
- Mutated rep encoding sequences for use in AAV production31US 9,228,174 B2uniQure IP B.V. · 2016